The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review

BACKGROUND: Checkpoint inhibitor immunotherapy has not proven clinically effective in glioblastoma. This lack of effectiveness may be partially attributable to the frequent administration of dexamethasone in glioblastoma patients. In this systematic review, we assess whether dexamethasone (1) affect...

Descripción completa

Detalles Bibliográficos
Autores principales: Swildens, Kyra X, Sillevis Smitt, Peter A E, van den Bent, Martin J, French, Pim J, Geurts, Marjolein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389427/
https://www.ncbi.nlm.nih.gov/pubmed/35990704
http://dx.doi.org/10.1093/noajnl/vdac087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389427/
https://www.ncbi.nlm.nih.gov/pubmed/35990704
http://dx.doi.org/10.1093/noajnl/vdac087

Ejemplares similares